A detailed history of Core First Bank & Trust transactions in Pfizer Inc stock. As of the latest transaction made, Core First Bank & Trust holds 9,761 shares of PFE stock, worth $245,293. This represents 0.19% of its overall portfolio holdings.

Number of Shares
9,761
Previous 28,883 66.21%
Holding current value
$245,293
Previous $801,000 65.92%
% of portfolio
0.19%
Previous 0.5%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$25.26 - $29.6 $483,021 - $566,011
-19,122 Reduced 66.21%
9,761 $273,000
Q1 2024

May 15, 2024

SELL
$25.89 - $29.73 $343,637 - $394,606
-13,273 Reduced 31.49%
28,883 $801,000
Q4 2023

Mar 18, 2024

SELL
$26.13 - $33.94 $26,417 - $34,313
-1,011 Reduced 2.34%
42,156 $1.21 Million
Q3 2023

Dec 18, 2023

BUY
$32.09 - $37.51 $63,088 - $73,744
1,966 Added 4.77%
43,167 $1.43 Million
Q2 2023

Aug 07, 2023

SELL
$36.12 - $41.79 $84,015 - $97,203
-2,326 Reduced 5.34%
41,201 $1.51 Million
Q1 2023

May 15, 2023

SELL
$39.39 - $51.28 $54,358 - $70,766
-1,380 Reduced 3.07%
43,527 $1.78 Million
Q4 2022

Feb 15, 2023

BUY
$41.75 - $54.5 $4,509 - $5,886
108 Added 0.24%
44,907 $2.3 Million
Q3 2022

Nov 16, 2022

SELL
$43.76 - $53.42 $24,068 - $29,381
-550 Reduced 1.21%
44,799 $1.96 Million
Q2 2022

Aug 16, 2022

BUY
$46.53 - $55.17 $12,330 - $14,620
265 Added 0.59%
45,349 $2.38 Million
Q1 2022

May 16, 2022

SELL
$45.75 - $56.69 $15,966 - $19,784
-349 Reduced 0.77%
45,084 $2.33 Million
Q3 2021

Nov 15, 2021

BUY
$39.25 - $50.42 $26,807 - $34,436
683 Added 1.53%
45,433 $1.96 Million
Q2 2021

Aug 17, 2021

SELL
$35.91 - $40.68 $24,526 - $27,784
-683 Reduced 1.5%
44,750 $1.75 Million
Q4 2020

Feb 16, 2021

BUY
$33.47 - $42.56 $1.52 Million - $1.93 Million
45,433 New
45,433 $1.67 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $141B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Core First Bank & Trust Portfolio

Follow Core First Bank & Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Core First Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on Core First Bank & Trust with notifications on news.